| Aug 8 |
Silk Road Medical seesaws report Boston Scientific deal could see FTC 2nd request (update)
|
| Aug 8 |
OPKO Health (OPK) Q2 Earnings Top Estimates, Gross Margin Down
|
| Aug 8 |
PacBio (PACB) Q2 Earnings Beat Estimates, Revenues Down Y/Y
|
| Aug 8 |
McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y
|
| Aug 7 |
Nevro's (NVRO) Q2 Earnings Beat Estimates, Revenues Down Y/Y
|
| Aug 7 |
DaVita (DVA) Q2 Earnings & Revenues Top Estimates, Margins Up
|
| Aug 7 |
Masimo (MASI) Q2 Earnings Beat Estimates, Gross Margin Up
|
| Aug 7 |
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
|
| Aug 6 |
Baxter (BAX) Q2 Earnings Beat Estimates, '24 EPS View Raised
|
| Aug 6 |
3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX)
|
